DOI:

PUBMED/MEDLINE indexing

Patrick W. Serruys, Editor-in-Chief

Dear Colleagues,

Our years of work, of steady collaboration and communications, has now been recognised, and our journal – your journal – EuroIntervention has been accepted for indexing by MEDLINE/PUBMED. As we search for information on the web, as we prepare our publications and our submissions, we perhaps have taken for granted this simple act of recognition, and yet it represents an objective judgment of what we are up to, as well as an invaluable tool for the future. We are proud of this achievement, but aware at the same time that our work has only just begun.

We have learned that during recent this review period we were one of 143 titles being considered from throughout the world. The review took place at the United States department of Health and Human Services, the National Institutes of Health, at the National Library of Medicine in Bethesda, Maryland by a committee of 19 members of the Literature Selection Technical Review Committee. The final process itself took over two days, and we have been accepted before JACC Intervention / Circulation intervention, who, as you know, are younger publications in our field.

New commitments

So now is the time to commit ourselves again. Commit ourselves to an increased publication schedule of 6 times a year. Commit ourselves to an expediated review process. Commit ourselves to a stringent acceptance policy based on the highest standards of peer review. Commit ourselves to fulfilling our next goal: an indexing factor that we can all be proud of.

This year begins with underlining the increasing and close collaboration between the European Heart Journal team and EuroIntervention. This is something we have spoken about before, and is due in great part to the warm support of our friend Thomas Lüscher and his team in Zurich. This seemingly natural and mutually beneficial situation can be witnessed by the recent online joint publication of the ESC/DES Task Force paper focusing on “The worldwide discussion on the long-term safety and efficacy of DES whose overall goal is to provide general recommendations to the medical community for the use, clinical development, and future assessment of DES” which is still available on our website.

Collaboration has always been one of the foundations of our work, and emerging technologies and techniques figure strongly within the pages of our journal. Work in structural heart disease will be augmented under the editorial direction of such names as Carlos Ruiz, Philip Bonhoeffer, Peter de Jaegere and with the support of Alex Vahanian (also Supplements Editor of EIJ) – who, I am sure you will agree – are well placed to help us focus better on these fast changing subjects.

And this issue will offer much more, here in print, but online as well. Paper such as Howard Hermann’s on “percutaneous mitral valve repair” or one on “bioabsorbable stents” by Hector Garcia-Garcia, as well as the above mentioned joint publication with the EuroHeart Journal, the “ESC forum on drug eluting stents” by Joost Daemen et al. Our “hands-on” section with a twist, “How Should I Treat” will be dealing with the issue of coronary steal with unstable angina secondary to a coronary artery fistula presented by Rohit Khurana, with expert commentaries by Ad Bogers and Shakeel Qureshi.

We will always try to remain true to the trust you place in us, by your submissions, by your loyal readership... and we are committed to evolving with the highest standards that you, and now the world, have come to expect.

Volume 4 Number 4
Jan 20, 2009
Volume 4 Number 4
View full issue


Key metrics

Suggested by Cory

Flashlight

10.4244/EIJ-D-24-01058 Jun 2, 2025
AMAC: Anchor the Mother to Advance the Child – a technique for complex PCI
Cocco N et al

Editorial

10.4244/EIJ-E-25-00018 Jun 2, 2025
Using pericoronary fat attenuation to guide management after coronary interventions
Antoniades C and Chan K
free

Editorial

10.4244/EIJ-E-25-00014 Jun 2, 2025
Polymer-free biolimus-eluting stents: there is no such thing as a free lunch
Piccolo R and Spitzer E
free
Trending articles
309.93

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
166.7

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
92.45

State-of-the-Art Review

10.4244/EIJ-D-20-01296 Aug 27, 2021
Management of cardiogenic shock
Thiele H et al
free
76

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
72.85

State-of-the-Art

10.4244/EIJ-D-24-00386 Feb 3, 2025
Mechanical circulatory support for complex, high-risk percutaneous coronary intervention
Ferro E et al
free
58.3

Clinical research

10.4244/EIJ-D-23-00344 Sep 18, 2023
Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation
Sanchez-Luna JP et al
free
56.65

Clinical research

10.4244/EIJ-D-20-01155 Oct 20, 2021
A deep learning algorithm for detecting acute myocardial infarction
Liu W et al
free
33.9

CLINICAL RESEARCH

10.4244/EIJ-D-17-00381 Oct 11, 2017
Stent malapposition and the risk of stent thrombosis: mechanistic insights from an in vitro model
Foin N et al
free
33.65

State-of-the-Art

10.4244/EIJ-D-23-00606 Jan 1, 2024
Targeting inflammation in atherosclerosis: overview, strategy and directions
Waksman R et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved